NCT01466777

Brief Summary

The aim of this study is to compare the robotic-assisted laparoscopic surgery to the traditional laparoscopic surgery in endometrial cancer patients. The study is prospective and the patients are randomised into two groups of 50 patients each. Randomisation is done with Minim-programme and patients age and Body mass index are taken into account. The primary endpoint is the operation time. The number of patients in this study is based on the non-inferiority design. Presumption is that the operation time in robotic-assisted laparoscopy will be 25% longer. Secondary endpoints include:

  1. 1.bleeding
  2. 2.complications
  3. 3.conversions
  4. 4.number of pelvic lymph nodes

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2011

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 8, 2011

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

June 6, 2019

Status Verified

June 1, 2019

Enrollment Period

8.8 years

First QC Date

August 18, 2011

Last Update Submit

June 5, 2019

Conditions

Keywords

Endometrium cancerRobotic-assisted laparoscopyTraditional laparoscopyLaparoscopic surgeryTreatmentOperation timeBleedingComplicationsConversionsPelvic lymph node

Outcome Measures

Primary Outcomes (1)

  • the operation time

    From the beginning of first wound incision to the closure of the wounds, an expected average of 3 hours

Secondary Outcomes (4)

  • bleeding

    Duration of hospital stay, an expected average of 5 weeks

  • Number of participants with adverse events

    Duration of hospital stay, an expected average of 5 weeks

  • Pain

    Duration of hospital stay, an expected average of 5 weeks

  • pelvic lymph node volumes

    Duration of hospital stay, an expected average of 5 weeks

Study Arms (2)

traditional laparoscopic surgery type

ACTIVE COMPARATOR
Procedure: Traditional surgery type

Robotic assisted operation type

EXPERIMENTAL
Procedure: Robotic assisted laparoscopic surgery

Interventions

Traditional laparoscopic surgery for endometrial cancer

traditional laparoscopic surgery type

Robotic assisted laparoscopic surgery for endometrial cancer

Robotic assisted operation type

Eligibility Criteria

Age30 Years - 85 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Endometrial cancer operations, which means hysterectomy, bilateral salphingo-oophorectomy and pelvic lymphadenectomy
  • Gr 1 and 2 differentiation type

You may not qualify if:

  • The operation cannot be made with an laparoscopy operation
  • Age more than 85 years or young under 30 years patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tampere University Hospital

Tampere, P.O.Box 2000, 33521, Finland

Location

Related Publications (1)

  • Vuorinen RK, Maenpaa MM, Nieminen K, Tomas EI, Luukkaala TH, Auvinen A, Maenpaa JU. Costs of Robotic-Assisted Versus Traditional Laparoscopy in Endometrial Cancer. Int J Gynecol Cancer. 2017 Oct;27(8):1788-1793. doi: 10.1097/IGC.0000000000001073.

MeSH Terms

Conditions

Endometrial NeoplasmsHemorrhage

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 18, 2011

First Posted

November 8, 2011

Study Start

November 1, 2010

Primary Completion

August 1, 2019

Study Completion

September 1, 2019

Last Updated

June 6, 2019

Record last verified: 2019-06

Locations